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1  Introduction
the development of alternatives to animal experimentation 
has received a major boost by the paradigm shift described 
in the NRC report on Toxicity Testing for the 21st Century: A 
Vision and a Strategy (NRC, 2007), where cell-based assays 
are suggested as major tools for risk assessment. the paradigm 
moves from phenomenological analyses of apical end points 
of toxicity in animal models to mechanistically-based assays 
using cells and cell lines. the knowledge obtained from sig-
naling pathways and cellular responses occurring in normal 
biological systems reacting to endogenous and exogenous sig-
nals is capitalized by this paradigm shift. When the duration 
or strength of perturbations is beyond the self-healing capacity 
of the homeostatic machinery, the normal pathways become 
toxicity pathways (tPs), whose perturbations are the basis of 
consequent adverse effects. It should be noted that this must be 
distinguished from the chemico-biological interaction leading 
to the perturbation. It appears that different chemico-biological 
interactions can result in the same perturbations. In fact, only a 
limited number of tPs corresponding to the limited number of 
hazard manifestations might exist. this may indicate that there 
are only a certain number of meta-stable homeostatic states 
which are subjected to stress by toxicants; they are considered 
meta-stable because they typically result in repair (return to 
original homeostasis) or damage.
A detailed characterization of normal molecular processes 
and their alterations into tPs, therefore, is expected to clarify 
relevant mechanism-based perturbations that can be exploited in 
toxicity testing strategies using cells and cell lines (NRC, 2007). 
the complexity of signaling pathways and networks currently 
known (see, for instance, Barabasi and Oltvai, 2004; Papin et 
al., 2005; Buchanan et al., 2010) is met by a limited knowledge 
of TPs. In fact, the characterization of TPs and the identification 
of key perturbations represent the major goals of the first phase 
of a research program (lakatos, 1978) to make the paradigm 
shift a reality (NRC, 2007).
In this paper, we will discuss some issues relevant to the identi-
fication and characterization of TPs and consequent perturbations, 
as well as features of cell-based assays for toxicity testing that 
capitalize on the knowledge on those pathways. It appears that 
different assays will be needed to identify tPs and later to test for 
their perturbation. In particular, we will outline some general mo-
lecular scenarios in normal functioning cells where relevant per-
turbations of physiological processes might ensue when systems 
become exposed to toxic agents/stressors. We will also examine 
examples of existing cell-based assays for the characterization 
of the molecular responses induced by toxic agents as means to 
clarify the mechanistic basis of their toxicity and their possible 
detection by specific, cell-based biomolecular assays. These top-
ics will then be examined to discuss features of applicability and 
scope, including the validation of the cell-based assays.
Summary
The call for a new toxicology is mainly a call for cellular approaches and their computational integration. 
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test specificity will change. Selective cell-based assays are desirable, especially for the detection of novel 
toxicants and biothreats. Examples from endocrine disruption, pyrogenicity, and especially shellfish toxin 
testing are used to illustrate such developments. 




will be instrumental in outlining the complexity of molecular 
consequences that may arise from the action of toxic agents on 
their specific molecular targets in varying scenarios. These con-
siderations will represent our background for further discussion 
of cell-based assays for toxicity testing.
the scheme of Figure 1 includes DNA replication, transcrip-
tion, and translation, as well as indications of a few basic func-
tions brought about by cellular proteins, such as the control of 
transcription by trans-acting transcription factors (tF), interme-
diary metabolism, and signal transduction. Relevant basal cellu-
lar processes, such as ion homeostasis or vesicle trafficking, for 
instance, have not been inserted in this scheme, as it only rep-
resents an oversimplification of minimal functional properties. 
The proposed scheme, however, encompasses some specific fea-
tures often encountered in pathways of intermediary metabolism 
and signal transduction, which will be instrumental in further 
discussions. the two hypothetical metabolic pathways of Figure 
1, including metabolites M1-M8 and the enzymes catalyzing in-
dividual reactions (e1-e7), for instance, include:
i) a reaction which connects the two pathways so that metabo-
lites M2-M4 can be products of a distinct series of reactions 
and have two different precursors (M1 and M5);
ii)  the end product of one pathway (M4) is a modulator of a 
protein component having a role of effector/transducer 
(eFy2) in a signaling pathway;
2  A mechanistic frame for toxicity pathways  
at a cellular level
the molecular machinery of cells is structured through basic 
processes bringing about and controlling the functioning of the 
system, hierarchically organized as depicted by the so-called 
Central Dogma (Crick, 1958, 1970). Signaling pathways and 
their perturbed versions (tPs), therefore, are parts of the full ma-
chinery, and emphasis on specific sequences of events in experi-
mental studies is often aimed at characterizing elements in the 
entire systems, either under normal conditions or in molecular 
toxicology settings (see, for instance, Rossini, 2005; Kholodenko, 
2006; Natarajan et al., 2006; Krewski et al., 2011; Rossini et al., 
2011). the normal functioning cell, in fact, must be considered as 
a network of components with relevant interactions between and 
among subsets of elements (Hartwell et al., 1999; Kholodenko, 
2006). In keeping with the complexity of biological systems, the 
major subsets of molecular processes composing the cellular ma-
chinery are outlined in Figure 1. We will use this scheme, from 
the perspective of toxicity testing, to examine different scenari-
os of possible perturbations caused by the exposure of cellular 
systems to toxicants/stressors leading to activation of tPs. this 
schematic representation must be viewed as an extremely simpli-
fied picture with minimal functions outlined and mostly ignoring 

































Fig. 1: Schematic representation of basic cellular functions
This simplified model includes major steps of gene replication and expression, as well as hypothetical metabolic and signaling pathways. 
TF, transcription factor; Sx and Sy, chemical signals; Rx and Ry, receptors of chemical signals Sx and Sy; EFx1-EFx6 and EFy1-EFy6, 
effectors of the signaling pathways of chemical signals Sx and Sy; E1-E7, enzymes catalyzing the reactions of metabolic pathways; M1-M8, 
intermediates of metabolic pathways. See text for explanations.
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and the specific perturbation caused by the gene mutation. Many 
examples of this kind of alteration exist in literature, as it is the 
molecular basis of diseases (including cancer), and results from 
malfunctioning key components of cell proliferation and the path-
ways controlling it (see, for instance, King et al., 2002; Weinberg, 
2006). Owing to the very extensive literature on mutagenesis and 
cell-based assays for detecting it (see the recent contribution by 
Boekelheide and Andersen, 2010), these will not be considered 
further. 
Perturbations leading to tPs can originate at levels of the bio-
logical system other than the genome. A toxic effect originates 
at the level of gene transcription when a toxic agent binds to and 
perturbs the function of tFs (Fig. 2). In this case, the toxicant 
causes an altered expression of the genes under the control of the 
targeted tF, resulting in changes in the cellular levels of the pro-
teins coded by those genes and, hence, an altered performance of 
functions as compared to that occurring in cells in the absence of 
the toxic agent. Several possible scenarios exist, including both 
positive and negative changes in the levels of proteins coded by 
the genes if transcription is de-regulated. the scenario outlined 
in Figure 2 includes transcription repression of genes encoding 
effectors (eFx5 and eFy5) and enzymes (e1 and e2), which would 
lead to impaired functions of those effectors, and to the blockade 
of one metabolic pathway. the cellular concentrations of metabo-
lite M4 would then depend on conversion of M7 into M2 catalyzed 
iii) the enzyme catalyzing the first reaction of one metabolic 
pathway (e1) is controlled by the action of an effector (eFx5) 
of a signaling pathway.
the two signaling pathways depicted in Figure 1, in turn, in-
clude other features found in living systems that are comple-
mented by those already indicated in points ii and iii above, and 
will be used in our discussions. these include:
i) cross-talks between pathways occurring at different steps;
ii) the functioning of one receptor (Rx) is controlled by an ef-
fector/transducer (eFx3) of the signaling pathway triggered 
by the incoming signal (Sx);
iii) an effector/transducer of a signaling pathway (eFx6) con-
trols the functioning of a transcription factor, thereby modu-
lating the transcription of selected genes.
toxic agents and stressors may affect a biological system by 
interfering with proper functioning of one or more processes 
outlined in Figure 1. Mutagens, for instance, may chemically 
modify DNA, leading to transcription of RNA, whose altered 
sequence may be translated into proteins with modified amino 
acid sequences. If the altered primary structure of the synthesized 
protein determines a severely perturbed function, and the pro-
liferation of the cell containing the mutated gene continues, the 
process brought about by the altered protein may be disrupted 
in the organism. In this scenario, the severity of the adverse ef-
































Fig. 2: Alterations in cellular functions induced by a toxicant targeting a transcription factor
The proposed scenario is one of the multiple hypothetical alternatives that can be framed by the scheme reported in Figure 1. TX, 
toxicant. Other abbreviations are as indicated in the legend to figure 1. The portions of processes altered by the toxicant in this scenario 




termediate effector (eFx4 on eFy4). the outcome of this alteration 
in this model would then depend on the exposure of the system 
to Sy, as cell functioning dependent upon eFy4 and eFy5 would 
occur only if signal Sy would turn its signaling pathway on, lead-
ing to activation of eFy3 (Fig. 3). Similar considerations can be 
put forward regarding possible effects of the toxicant on gene 
transcription in this model, as the functioning of tF is postulated 
to be controlled by eFx6. this effector, however, would partici-
pate in cross-talks between the two pathways, and malfunction-
ing in exposed cells could be compensated by the signaling of Sy 
(Fig. 3). Other consequences of cell exposure to the toxicant in 
this scenario would include the loss of regulatory mechanisms 
exerted by eFx3 on Rx and a change in the metabolic pathways 
leading to production of M4, which would be obtained from M5 
through the reaction catalyzed by e6 (e1 would not be activated 
by eFx5 under these conditions). Within this frame, the regulatory 
circuitry involving M4 and eFy4 would be operative if the cellular 
concentrations of the modulator (M4) in cells exposed to the toxi-
cant were within the physiological range, but would be perturbed 
if the flow of intermediates in the pathways were inadequate in 
the presence of inactive e1. 
A variety of possible biological systems scenarios can be hy-
pothesized, some of which have been introduced in our mod-
els. It should be stressed that the models devised to account 
for possible perturbations of TPs represent oversimplifications, 
by e6, and the possible decreased levels of M4 resulting from this 
alternative pathway as a consequence of the toxicant. this could 
lead to an impairment of the controlling circuitry of the pathway 
of signal Sy exerted through the effector eFy2 (Fig. 2). thus al-
terations exerted at a transcriptional level may have secondary 
consequences brought about by components participating in dis-
tal steps of a tP, whose activity is affected by cross-talks between 
distinct pathways.
endocrine disrupters are toxicants interacting with tFs 
through mechanisms similar to those outlined in Figure 2. Cell-
based assays built upon those mechanistic features and used for 
toxicity testing of compounds to probe endocrine disruption 
will be considered in the next section.
Many toxicants act on components of signal transduction and 
other regulatory pathways in biological systems. A possible sce-
nario is depicted in Figure 3, as a background to further discus-
sion about features and consequences of perturbations. the target 
of a toxicant in Figure 3 is an effector/transducer acting at an 
early step in a signaling pathway, and the consequence proposed 
for this event is a blockade of signal transduction controlled by 
signal Sx. Owing to the structure of the proposed pathway, the 
perturbations caused by this toxicant would not be confined to the 
functions controlled by signal Sx through its own effectors, but 
would also include processes regulated by Sy as a consequence of 

































Fig. 3: Alterations in cellular functions induced by a toxicant targeting an effector of a signaling pathway
The proposed scenario is one of the multiple hypothetical alternatives that can be framed by the scheme reported in Figure 1. TX, 
toxicant. Other abbreviations are as indicated in the legend to Figure 1. The portions of processes altered by the toxicant in this scenario 
are shown in light gray, and major processes/components involved in this perturbation are circled by a red dotted line. See text for 
explanations.
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which include only some molecular mechanisms of toxins. For 
instance, the possibility that an agent might directly alter the 
ultrastructure, and hence the functional properties of a cellular 
organelle (as is the case for the bee poison melittin which forms 
channels in the plasma membrane (Bechinger, 1997)), has not 
been considered in these models, but the mechanistic features 
and consequences of this type of perturbation can be framed by 
our reasoning. Similar considerations can be applied to agents 
directly interacting with enzymes responsible for the metabolism 
of endogenous physiological modulators, such as organophos-
phate pesticides acting on acetylcholinesterases (Costa, 2006), 
which have not been examined in the light of the scheme of Fig-
ure 1, but can frame the resulting molecular perturbations. Fur-
thermore, adsorption, distribution, metabolism, and excretion 
have not been included in our discussion, although toxicokinet-
ics must be taken into account to develop robust risk assessment 
based on the use of cellular assays.
In general terms, the set of alterations induced by a toxicant in 
biological systems depends on the structure of the systems them-
selves. In turn, the severity of alterations, and hence the conse-
quences of system exposure to a toxicant, depends on more quan-
titative issues, including, but not limited to, the toxicant dose and 
time of exposure. Considering the scenarios depicted in Figures 2 
and 3, for instance, it is apparent that whether alterations induced 
by a toxicant may become perturbations transforming normal 
molecular processes into tPs (and resulting in measurable ad-
verse effects) depends on several factors inherent in the molecu-
lar processes altered by the toxicant and on the specific conditions 
existing in the system and its environment. A detailed knowledge 
of the molecular players in cellular processes and their regulatory 
circuitry is needed to identify perturbations which might eventu-
ally become responsible for adverse effects in the resulting tP. 
thus, the knowledge needed to support the development of ro-
bust cell-based assays for toxicity testing should include the char-
acterization of the relevant node(s) of any molecular mechanism 
of action whose alteration(s) would make a normal pathway a 
tP. Although the structure of the machinery can be the basis for 
rational hypotheses, careful experimental analysis of processes 
and the outcomes resulting from their alterations is mandatory to 
establish evidence-based alterations which may be robustly as-
sociated with specific TPs and adverse effects. Due to the com-
plexity of these networked events, systems approaches modeling 
these non-linear interactions as a type of virtual experiment will 
be increasingly necessary (Hartung et al., 2012).
3  A utilitarian approach to cell models
Utilitarianism judges the moral worth of an action only by its 
resulting outcome: “The end justifies the means.” In the best of 
all possible worlds, we would use the test system most closely 
representing the physiology in question, which would mean – in 
decreasing order – the relevant human population, a phyloge-
netically close animal species, an organotypic cell culture, and 
so on, with many in-between steps. there are many reasons to go 
down the ladder to the more simple systems (ethics, feasibility, 
costs, throughput). We might argue that we should use the high-
est ranking system affordable for a given purpose because we 
would expect better results. When restricting ourselves to cel-
lular models, the concept of a “human on a chip” (Hartung and 
Zurlo, 2012) follows such thinking. However, we have seen that 
some of the most successful test systems are the simplest, e.g., 
the Ames test in bacteria (still the most predictive mutagenic-
ity test, Kirkland et al., 2005) or the limulus Amebocyte lysate 
test. What the simple systems lose with regard to physiologi-
cal resemblance they gain from the higher number of replicates, 
ease of interpretation of results, and reproducibility (reduction in 
systematic and random errors). the more components or work 
steps in a test system, the more things can go wrong and need to 
be controlled.
the utilitarian approach likely to be most successful is the 
one that uses the simplest test system that gets the job done. For 
TP identification, this means that a system that shows a hazard 
manifestation will allow TP identification (notably, not all TP) 
if alternative routes can lead to the same phenotype. However, 
it is likely to be easier to use a number of test systems which 
together cover all the relevant reference toxicants than trying to 
find a single test system that almost completely reflects human 
pathophysiology. 
4  Learning from existing models
the general considerations of molecular bases of perturbations 
and their role in tPs outlined above represent the framework for 
examining examples of cell-based toxicity testing models. the 
following discussion will consider two major lines of intervention 
that have been devised to approach different aspects of the same 
issue. On the one hand, we will consider models developed prima-
rily to assess hazard and the molecular basis of toxicity. Secondly, 
we will consider cell-based assays for detection and measurement 
of specific classes of toxic compounds by biomarkers/signatures 
of selected cellular responses. this approach is not strictly aimed 
at toxicity testing, but rather extends to many cell-based method-
ologies capitalizing on the knowledge of molecular mechanisms 
of action of toxic agents/stressors to perform biological assays 
of materials suspected to contain those toxic agents/stressors to 
obtain qualitative/quantitative information regarding the toxicity 
attributable to that class of agents in those samples.
the cell-based assays for different classes of agents presented 
in this section are not aimed at providing a full account of the ex-
isting literature, but at pinpointing major features and approaches 
that have been devised in different analytical settings. Further-
more, our discussion will highlight their potential (and possible 
critical) points with regard to their area of application to support 
further efforts in the development of cell-based procedures.
Cell-based assays for toxicity testing
The first approach of cell-based assays for toxicity testing to be 
considered in this section captalizes on the robust knowledge of 
the molecular mechanism of action of estrogens, which has been 
established over the last fifty years. In 1962, with the use of high 
specific activity tritiated 17β-estradiol, Elwood V. Jensen’s group 
provided the first firm evidence regarding the existence of recep-
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and O’Malley, 2000; Lonard and O’Malley, 2006), including re-
sponses to endocrine disrupters (Safe et al., 2002; Shanle and xu, 
2011). these features may be altered either directly or indirectly 
by endocrine disrupters, which can induce cellular responses by 
binding to other receptor components acting as transcription fac-
tors, such as the aryl hydrocarbon receptor, leading to cross-talk 
between distinct signaling pathways (Safe and Wormke, 2003; 
Rüegg et al., 2008). endocrine disruption would then result from 
the combined action of a non-physiologic set of proteins syn-
thesized following the expression of a perturbed mRNA pool in 
affected cells (Fig. 4, right panel).
Although it must be stressed that tPs of endocrine disruption 
are more complex than the simplified scheme we have outlined, 
involving additional molecular systems and the contribution of 
multiple tissues (Hotchkiss et al., 2008; Shanle and xu, 2011), 
the role of altered transcriptional responses induced by distinct 
receptor systems and their cross-talk is accepted, providing 
further support for the use of cell-based assays detecting tran-
scriptional responses of estrogen action. Overall, this is a clear 
indication that robust information about tPs can be obtained 
when the molecular mechanisms of normal functions are well 
characterized, lending further support to the notion that major 
efforts to characterize the basic molecular machinery of living 
systems represent the necessary background for the develop-
ment of mechanistic-based cellular assays conveying reliable 
information for toxicity testing.
In fact, estrogenic endocrine disruption has been a very ac-
tive field of in vitro test development in recent years. the state 
of the art was recently summarized on behalf of the european 
Commission (Kortenkamp et al., 2011). the report has received 
quite some criticism (Rhomberg et al., 2012), which we won’t 
discuss, as our concern is the overall relevance of the hazard 
(Dietrich, 2010). The case shows, however, that specific con-
cerns can be translated to specific assays, i.e., when a mecha-
nism is known, mechanism-based tests can be put forward.
Similarly, other areas where toxicity mechanisms are reason-
ably well understood are on the brink of substitution by mech-
anism-based in vitro tests, e.g., skin sensitization (Basketter et 
al., 2012) and some topical toxicities (Zuang et al., 2008). 
Cell-based methods for the detection of toxic agents
Biological assays using cells and cell lines to detect toxic com-
pounds have received attention in several areas, including that of 
microalgal toxin-contaminated seafood and pyrogenicity testing. 
In these areas, instrumental procedures have not been available 
and/or fully validated for the measurement until recently, a con-
dition which has necessitated extensive use of animal bioassays 
(mostly mice to test for microalgal toxins in seafood and rab-
bits for microbial contaminants). Past eC legislation required 
the use of mouse bioassays for the detection of some lipophilic 
toxins in contaminated shellfish to protect consumer health (EU, 
2005). The lack of specificity of these bioassays and the ethical 
concerns linked with the extensive use of animals for analyti-
cal purposes have been the major driver for the development of 
cell-based assays (Rossini, 2005; Hess et al., 2006; Schindler et 
al., 2006, 2009). the pyrogen test in rabbits, in place for more 
than 40 years, was largely replaced by a test with correlative 
tors for estrogens in their target tissues (Jensen and Jacobson, 
1962), paving the way for the clarification of the molecular mech-
anism of action of a large superfamily of trans-acting transcrip-
tion factors and their ligands. Studies in subsequent years have 
led to firm conclusions about the molecular mechanisms by which 
estrogens control many aspects of cell functioning and differen-
tiation, including their roles in relevant pathological states such 
as mammary gland and endometrial cancer (Hewitt et al., 2005; 
Fuqua, 2009). Briefly, the binding of an estrogenic compound to 
its receptor in nuclei of target cells leads to a ligand-dependent 
change in the structure of the receptor protein accompanied by a 
modification of the binding affinity of estrogen-receptor complex 
for specific DNA sequences in the nuclear genome (Klein-Hitpass 
et al., 1988; Mangelsdorf et al., 1995; Biggins and Koh, 2007). 
the homodimerization of agonist-receptor complexes is then fol-
lowed by their binding to these DNA sequences termed estrogen-
responsive elements (eRe) and this interaction leads to changes 
in the transcription of selected genes (Fig. 4, left panel). the RNA 
produced as a consequence of cell exposure to estrogens is used 
for the synthesis of proteins that bring about the estrogenic re-
sponse in target cells, as has been established long ago (O’Malley 
and McGuire, 1968). Although studies in the last twenty years 
have led to the recognition that the molecular mechanism of es-
trogenic action can be more complex and would also include non-
transcriptional responses (see, for instance, Norman et al., 2004; 
Wehling and lösel, 2006), the basic model of estrogen-dependent 
regulation of gene transcription has not been challenged, and re-
mains the paradigmatic representation of the molecular mecha-
nism controlling gene expression in eukaryotes. In keeping with 
this view, the clarification of the molecular bases of transcriptional 
responses to estrogens, and the characterization of the base se-
quence of the eRe, have been fundamental in the understanding 
that these molecular steps are key players of estrogenic responses. 
this general conclusion led to the development of methods for a 
variety of biological studies, of which detection of estrogen-sen-
sitive processes is just one example. the general structure of cell-
based assays using basic features of transcriptional responses in 
estrogen-responsive systems includes a cell expressing estrogen 
receptor genetically engineered to include a reporter gene whose 
transcription is under the control of an eRe, as was the original 
experimental strategy of Klein-Hitpass et al. (1988). exposure of 
these systems to agents possessing estrogenic activity results in 
enhanced expression of reporter genes, supporting conclusions re-
garding the estrogenic activity of the agent of interest.
this type of assay has been used for toxicity testing of endo-
crine disrupters (for recent reviews, see Hotchkiss et al., 2008; 
Shanle and xu, 2011). Some estrogen disrupting chemicals, in 
fact, can interact with estrogen receptors and cause transcrip-
tional responses induced by estrogens under normal conditions 
(Naciff and Daston, 2004; Shanle and xu, 2011). this mechanis-
tic element has been incorporated into the schematic represen-
tation of the molecular bases of endocrine disruption shown in 
Figure 4 (right panel). Multiple structural features, however, de-
termine transcriptional responses involving the estrogen receptor 
system at the level of ligands, receptor forms, and transcriptional 
co-factors/activators contributing to changes in the transcription 
of selected genes (see, for instance, Shiau et al., 1998; McKenna 
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duced in the eU (eU, 2011), efforts aimed at the development 
of cell-based methods has continued, as they are considered of 
higher value for some purposes. efforts in this area are sup-
ported by the recognition that naturally contaminated materials 
often include many distinct analogues (MacKenzie et al., 2002; 
Aasen et al., 2005; Dell’Aversano et al., 2008; Rehmann et al., 
2008) of varying potency, pinpointing the need to quantify the 
full series of compounds with toxicological relevance. A second 
line of intervention recognizes that contamination of seafood by 
microalgal toxins has been evolving over the years, and novel or 
atypical contaminations have been detected (Moore and Scheu-
er, 1971; Hu et al., 1995; Deeds and Schwartz, 2010; ledreux 
et al., 2012). thus, cell-based assays, which have the potential 
to detect toxicologically relevant components of both character-
ized toxins and novel agents, have been sought. Some approach-
es to the development of these assays will be considered in this 
section, with a focus on seafood contaminated by microalgal 
toxins, which provides interesting case studies.
First attempts to develop cell-based assays for biotoxins con-
taminating shellfish included the analysis of morphological fea-
tures of cells exposed to toxins (Aune, 1989; Amzil et al., 1992). 
but not mechanistic similarity. the observation that horseshoe 
crabs react to bacteria with a clotting reaction was translated into 
an assay for endotoxin, though it misses pyrogens from Gram-
positive bacteria, fungi, etc. and does not represent the potency 
of different endotoxins in humans. these and some other prob-
lems, such as untestable products and false-positive reactions, 
were only overcome by the creation of assays based on the hu-
man mechanism of fever induction. the immune recognition 
of Gram-negative endotoxin has been largely elucidated, with 
the blood monocyte identified as the major sensing cell and cy-
tokines such as interleukin-1β identified as key messenger mol-
ecule. the discoverer of this mechanism and, in particular, of the 
relevant receptors, received the Nobel Prize 2011. the respective 
microbial counterpart and its human receptor are still not known, 
though evidence is increasing (Rockel and Hartung, 2012). this 
shows that where a mechanism is not completely known, the use 
of human primary cells in a physiologic/organotypic environ-
ment is the best approximation of a functional assay. 
With regard to microalgal toxins in shellfish, although regu-
latory recognition of instrumental methods for lipophilic toxin 
detection in contaminated materials has been recently intro-
Fig. 4: Schematic representation of transcriptional mechanisms of estrogenic responses (left panel) and their alteration by 
endocrine disrupters (right panel)
E, natural estrogen; ED, endocrine disrupter; RE, estrogen receptor; RAh, aryl hydrocarbon receptor; ER, estrogen-receptor complex; 
EDRE, endocrine disrupter-estrogen receptor complex; EDRAh, endocrine disrupter-aryl hydrocarbon receptor complex;  
CoF, transcriptional co-factor. The dashed lines indicate possible cross-talk between signaling pathways of different receptors.  
See text for details.
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thus allowed for a clever arrangement of agents, leading to re-
sponses of undeniable specificity in the stimulus determining 
the life or death fate of neuroblastoma cells. this mechanistic 
approach provides a readout of cell responses which is informa-
tive in both qualitative and quantitative terms. Cell survival, in 
fact, depends on the presence of Stx in the materials challeng-
ing the cells, and quantitative estimates of the total content of 
toxin (in equivalents) can be obtained by interpolating data in a 
dose-response curve of the assay, using an appropriate standard 
toxin (Kogure et al., 1988; Gallacher and Birkbeck, 1992; Jellett 
et al., 1992; Manger et al., 1993).
If the general features of the neuroblastoma assay are put 
into perspective, it can be argued that the response is function-
specific rather than toxin-specific. In fact, the assay can detect 
chemically distinct compounds, such as tetrodotoxin and Stx, 
which share the property to bind site 1 of NaV and block sodium 
conductance (Kogure et al., 1988). the neuroblastoma assay, 
therefore, illustrates two important aspects of cell-based assays 
to detect toxic agents/stressors. The first refers to the specificity 
of a cell-based assay, which is determined by the mechanistic 
constraints imposed on the system by the structure of the assay 
itself. In the case of the neuroblastoma assay, a pretreatment 
of cells with veratridine and ouabain confines cell readouts to 
effects resulting from the impairment of Na homeostasis in the 
cellular system. the second point is that cell-based assays are 
function-related. Other compounds sharing the molecular mech-
anism of action of Stx, such as tetrodotoxin, can induce the 
same results in the neuroblastoma assay. these features are not 
confined to the neuroblastoma assay, however, and are shared 
by cell-based methods in broader terms, as will be further dis-
cussed in the following examples. Whether these features might 
represent a limitation or an advantage essentially depends on 
the purpose of any assay. In fact, the depth and breadth of the 
The significant degree of subjectivity inherent into analysis of cell 
morphology and the non-specificity of cytotoxicity assays have 
eventually led to efforts aimed at developing procedures based on 
the analysis of responses that could be mechanistically linked to a 
toxin and would then represent a toxin-specific readout.
the prototype of mechanistic-based cellular assays for the de-
tection of toxins was developed in 1988 (Kogure et al., 1988). 
It was devised to detect toxins blocking voltage-gated sodium 
channels (NaV), such as tetrodotoxin, as well as saxitoxin-
group compounds (Stx), which are responsible for paralytic 
shellfish poisoning (Rossini and Hess, 2010). These compounds 
are known to bind to site 1 of the α-subunit of NaV, blocking 
the entrance of the ion into the cell (Castèle and Catterall, 2000; 
Rossini and Hess, 2010). the loss of sodium conductance in 
excitable cells, as a consequence of their exposure to Stx, 
prevents membrane depolarization and the transmission of the 
action potential, leading to impairment of neuromuscular func-
tion in the organism (Rossini and Hess, 2010). the cell-based 
method developed to detect Stx capitalized the knowledge of 
its molecular mechanism of action in excitable cells and exploit-
ed a neuronal cell line, which then gave its name to the proce-
dure – the neuroblastoma assay (Kogure et al., 1988; Gallacher 
and Birkbeck, 1992; Jellett et al., 1992; Manger et al., 1993). 
In this assay, cells are exposed to veratridine, leading to open-
ing of NaV, and to ouabain, blocking Na+,K+-AtPase and the 
extrusion of sodium from the cells, causing the impairment of 
ion homeostasis in neuroblastoma cells resulting in cell death 
(Fig. 5). If veratridine/ouabain-treated cells are exposed to Stx, 
the toxin blocks NaV and sodium entrance, preventing sodium 
accumulation into neuroblastoma cells and allowing their sur-
vival. the knowledge of the mechanism of action of Stx and 
of cellular physiology, as well as the use of pharmacological 
tools targeting specific cellular components and processes, has 
Fig. 5: General structure of the neuroblastoma assay for saxitoxin-group toxins
In the absence of saxitoxin (STX), veratridine/ouabain treatment induces a collapse of Na+ homeostasis, resulting in cell death (left 
panel). If veratridine/ouabain-treated cells are exposed to saxitoxin, it associates with voltage-gated sodium channels (NaV) and blocks 
Na+ entrance into the cells, preventing cell death and allowing cell survival (right panel). See text for details.
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The implications of those findings have supported further 
studies on the molecular mechanisms of action of Ytx and 
AZA-groups of compounds, leading to the conclusion that the 
accumulation of the 100 kDa e-cadherin fragment is caused by 
inhibition of endocytosis (Callegari, and Rossini, 2008; Bel-
locci et al., 2010). These specific issues will not be discussed 
further here; instead we will confine our attention to some heu-
ristic indications provided by those findings that are relevant for 
the framework of cell-based methods for the detection of toxic 
agents/stressors. 
the two cell-based assays for the detection of microalgal tox-
ins reported above exemplify the different potential of readouts 
with regard to the specific recognition of chemicals, depending 
on the degree of knowledge of molecular processes involved 
in the response to individual agents and their tPs. the major 
molecular features of neuronal transmission and the role played 
by sodium ions in this process are known at a depth which can 
support the development of a cellular assay fit for the purpose 
of detecting components perturbing one of the effectors of the 
response. the full tP of the agent, in this case, could be repre-
sented by a scheme similar to that reported in Figure 3, where 
receptor and effectors/transducers could be mostly defined in 
molecular terms. In the case of the e-cadherin assay, the incom-
plete knowledge about the molecular mechanism of action of 
Ytx and AZA would provide only a partial account of a proc-
ess (Rossini and Hess, 2010). In this case, the scheme could be 
structured as in Figure 3, but the lack of knowledge of recep-
tors and relevant effectors would hamper a detailed description 
of their full tPs. the recognition that the detection of the 100 
kDa e-cadherin fragment occurs when endocytosis is blocked, 
however, can be exploited in analytical settings. the accumu-
lation of the 100 kDa e-cadherin fragment in epithelial cells, 
in fact, could become a molecular biomarker of response for 
agents blocking protein degradation through endocytosis and 
lysosomal disposal, representing a function-specific, rather than 
a toxin-specific, molecular biomarker.
Overall, the detection of toxic compounds by the use of cells 
and cell lines implies a specificity issue which must be taken 
into account whenever considering the development of proce-
dures. the readout used to detect the response of the cellular 
system to the agent in question, therefore, should be linked to 
its inducer by cause-effect relationships, and appropriate knowl-
edge of the molecular mechanism of action of the agents to be 
detected is needed.
5  Looking for new robust models
The full elucidation of TPs and the identification of their rate lim-
iting points represent two pre-requisites for the development of 
robust assays for the evaluation of perturbations of toxicity testing 
(NRC, 2007). Biomarkers are to be found among the components 
of the normal pathways participating in rate limiting processes 
affected by toxicants. Biomarkers, therefore, would represent the 
molecular components whose altered biological activity indicate 
malfunctioning of the system and consequent adverse effects due 
to abnormal cellular levels and/or modified structural features. 
knowledge available on the molecular mechanism of action of 
selected agents/stressors determines the potential of individual 
cell-based procedures.
Some interesting features of these concepts can be illustrated 
by another example of a cell-based assay for detection of yesso-
toxins (Ytx), another class of natural products from microalgae. 
the human toxicity of this class of compounds by oral exposure 
is debated (eFSA, 2008) and some analogues of the group have 
been regulated by the eU (eU, 2004). At the beginning of this 
century, YTX-group compounds were classified among the di-
arrhetic shellfish poisoning (DSP) complex and were regulated 
as such (eC, 1991), without distinguishing the different chemical 
classes of lipophilic toxins, including dinophysistoxins (Dtx), 
Ytx, pectenotoxins (Ptx), and azaspiracids (AZA). Knowledge 
accumulated about these different substances, creating distinc-
tions with regard to chemical properties and toxicity and lead-
ing to distinct limits for the different classes of compounds (eC, 
2002). the analytical tools for the detection of those groups of 
compounds in shellfish, however, were not fully developed, pos-
ing serious difficulties for monitoring contaminations and risk 
management. Past eU legislation required the mouse bioassay 
for the detection of different classes of lipophilic toxins. Since 
this represented an unspecific tool, it provided a strong drive 
for the development of alternatives for the specific detection of 
toxins belonging to different chemical groups (Rossini, 2005; 
Hess et al., 2006). One such alternative was devised as a con-
sequence of a serendipitous observation. In the course of stud-
ies on the molecular responses induced by okadaic acid (OA), it 
was discovered that the reference compound of the Dtx group 
and Ytx affected the cell-cell adhesion molecule e-cadherin in 
different ways in an epithelial cell line. Cell exposure to OA, in 
fact, led to an overall loss of cellular protein with a concomi-
tant relative accumulation of the 135 kDa e-cadherin precur-
sor, whereas Ytx induced a prominent increase in the cellular 
content of a 100 kDa e-cadherin fragment. the toxin-selective 
effects were dose-related, and a cell-based method for the de-
tection of the two classes of compounds was developed (Patent 
Application, 2002). the characterization of the procedure for the 
detection of Ytx in naturally contaminated samples was then 
carried out (Pierotti et al., 2003). High doses of a Ptx analogue 
(Ptx-6) were not found to alter the e-cadherin molecule in the 
same model system, leading to the conclusion that the cell-based 
effect could be considered Ytx-selective and used for the de-
tection and measurement of this class of compound in shellfish 
material (Callegari et al., 2004),
the initial inclusion of AZA-group compounds among the so-
called DSP complex of lipophilic toxins, however, led to further 
studies on this assay because the procedure used for the prepa-
ration of samples to be subjected to analysis could also lead to 
extraction of AZAs (in case this contamination was present in 
the samples). Subsequent investigations were then carried out 
into the molecular responses induced by AZA-1 – the reference 
compound of AZA-group toxins – and showed that the accu-
mulation of the 100 kDa e-cadherin fragment could also be in-
duced by AZA-1 in that model system (Ronzitti et al., 2007). 
thus, the molecular marker used to detect Ytx by a cell-based 
assay was not specific, nor was the proposed procedure.
Rossini and HaRtung
Altex 29, 4/12368
Franco, 2011) that incorporate different mechanistic constraints 
for their specificity, such as the use of toxin-specific antibodies, 
an inhibitor of Na+,K+-AtPase (ouabain), and the structuring of 
the procedure aimed at detection of palytoxin-induced cytoly-
sis (Bignami, 1993; Bellocci et al., 2008, 2011; Cañete and Di-
ogène, 2008; Riobó et al., 2008). The insufficient knowledge of 
the actual toxicity of these substances in humans under different 
exposure conditions, however, as well as the incomplete charac-
terization of the molecular modes of action of palytoxin-group 
toxins and the relative potency of the analogues of the group, 
have hindered the exploitation of molecular biomarkers and cell-
based assays to provide robust quantitative estimates regarting 
the toxicity of suspected materials. existing cell-based assays, 
in fact, can be exploited to detect and quantify palytoxin-group 
toxins, but may not, at the moment, provide robust information 
about toxicity in humans and other organisms.
A second case refers to unexplained toxicity detected in some 
shellfish samples from the Arcachon Bay, France since 2005 
(Butler, 2006; ledreux et al., 2012). the issue was raised when 
the testing of shellfish extracts in the mouse bioassay gave posi-
tive results, i.e., mouse death within 24 hours of extract admin-
istration, but none of the already characterized classes of toxins 
was detected in those extracts, indicating that those materials 
most likely contained substances of atypical toxicity (ledreux 
et al., 2012). 
In the two cases mentioned above, the availability of cell-
based assays which could firmly link detection of selected bi-
omarkers to some recognized functional alteration would have 
provided significant information about toxicological features of 
not-yet-known/suspected toxicants. the incomplete information 
available regarding the human toxicity of palytoxin-group tox-
ins (eFSA, 2009), and the use of a cytotoxicity assay devoid of 
mechanistic-based constraints (ledreux et al., 2012), however, 
represent severe obstacles to the use of those cell-based meth-
ods for toxin detection. In more general terms, the availability of 
cell-based assays for the detection of function-specific responses/
perturbations would allow evidence-based predictions of defined 
toxicities of samples suspected to contain hazardous compounds 
independent of their state with regard to already established prop-
erties or yet-to-be-recognized toxicants. thus, cell-based assays 
detecting function-specific perturbations would allow transition 
from toxin-specific markers for the detection of something we 
already know about toward function-related markers for the de-
tection of something we do not know about (but might be haz-
ardous). By the same token, cell-based assays for the detection 
of function-specific responses/perturbations would provide toxi-
cological information about materials regardless/independent of 
their chemical characterization, and would represent valuable 
tools for the protection of human health and the environment 
from unpredictable toxicants and biothreats, as well as the dis-
covery of new biologically active chemicals.
6  Cell-based assays tailored for specific needs
Robust predictions about the toxic potential of agents tested by 
cellular systems strictly depend on the principle that mechanis-
The qualification of a cell-based assay, then, depends on the ro-
bustness of the biomarker, with reference to its potential for re-
porting the conversion of a normal pathway into a tP.
In the examples provided in the previous section, the respons-
es detected by cell assays could be viewed as biomarkers of al-
tered functioning within a tP whenever appropriate knowledge 
of key steps of the normal pathway had been established. the 
detection of a transcriptional response under the control of an 
eRe and the perturbation of Na+ homeostasis, in fact, would 
not provide uncertainties about their functional consequences in 
biological systems. Still, endocrine disruption is recognized to 
include perturbation of endocrine systems in addition to the es-
trogen receptor (Shanle and xu, 2011), highlighting the impor-
tance of an integrated approach in the characterization of nor-
mal pathways and tPs. In other words, the presence of known 
physiological mechanisms increases the likelihood of the pres-
ence of others that are not yet identified. 
the importance of cell-based assays, with features support-
ing firm conclusions of specific toxic effects of tested substances 
based on mechanistic considerations, is obvious. It seems ap-
propriate, however, to stress that the scope of such assays can 
be much wider. Whenever molecular biomarkers of a toxic ef-
fect are identified and exploited in a robust cell-based assay, the 
procedure can become a tool for testing whether an unknown 
sample could effectively contain agents with that identifiable 
toxic activity. Both the environment and humans might become 
unpredictably exposed to new, or else undetermined, toxic sub-
stances, and getting prompt insight into the toxicological poten-
tial of those agents may be of great societal relevance. two areas 
of exploitation of functional cell-based assays would include 
protection from bioterrorism and the detection of new toxic sub-
stances in the environment.
existing scenarios indicate that these possibilities may not be 
confined to fiction, and we will limit this discussion to some re-
cent examples of natural substances whose features might have 
a wider applicability.
Blooms of microalgae of the genus Ostreopsis have been 
recorded with increasing frequency and geographical expansion 
in waters of temperate countries in the last twenty years (Ga-
litelli et al., 2005; Penna et al., 2005; Aligizaki and Nikolaidis, 
2006; tichadou et al., 2010). Ostreopsis algae are known to 
produce toxins classifiable among the palytoxin-group (Usami 
et al., 1995; Ciminiello et al., 2006). this group includes large 
polyether molecules which are recognized to bind to Na+,K+-
ATPase and convert the ion-specific pump into a non-specific 
cation channel (reviewed in Rossini and Bigiani, 2011). the 
toxic potential of palytoxin-group substances in humans is still 
being discussed (eFSA, 2009; tubaro et al., 2011), but concerns 
were raised in 2005 when approximately 200 people were admit-
ted to hospitals in Genoa, Italy with symptoms involving prima-
rily the respiratory tract after being at the coast in areas where 
blooms of O. ovata were taking place (Durando et al., 2007). 
Similar cases have been recorded in other Mediterranean coun-
tries (Aligizaki et al., 2008, 2011), but formal proof of cause-
effect relationships between the Ostreopsis blooms and human 
illnesses is still lacking. Cell-based assays are available for the 
detection of palytoxin-group toxins (reviewed in Riobó and 
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would pertain primarily to molecular mechanisms controlling 
cellular functioning, whereas converging/diverging metabolic 
reactions often represent the basic processes of cellular systems 
and housekeeping functions. these few examples provide only 
a very limited account of the full range of interacting sub-sys-
tems existing at a cellular level, whose overall structure encom-
passes a hierarchical organization as captured by the Central 
Dogma and the flow of information from nucleic acids to pro-
teins (Crick, 1958, 1970).
Mechanistic descriptions of cellular processes and their per-
turbations should take into account this complexity (Buchanan 
et al., 2010). Cell-based assays developed for toxicity testing and 
other areas should capture the complexity underlying selected 
processes and convey the relevant biological information into re-
adouts to account for the mechanistic bases of their occurrence, 
thereby embodying the specificity of a recognizable functional 
perturbation. the development of procedures tailored to detect 
specific functional alterations will be a driver for the establish-
ment of effective suites of cell-based assays for toxicity testing 
that support mechanistic-based risk assessment and for their use 
as alternatives to animal experimentation. In all instances, ade-
quate quality assurance is necessary to safeguard reproducibility 
and reliability of results. Validation of cell models has pioneered 
such quality assurance, but much work still needs to be done to 
create a culture of evidence-based science.
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